| Adjusted | Adjusting | Statutory | Adjusted | Adjusting | Statutory | ||
| total | items | total | total | items | total | ||
| 2026 | 2026 | 2026 | 2025 | 2025 | 2025 | ||
from continuing operations | notes | £’000 | £’000 | £’000 | £’000 | £’000 | £’000 |
Revenue | 2 | ||||||
Cost of sales | 4 | ( | ( | ( | ( | ( | ( |
Gross profit | ( | ( | |||||
Distribution costs | ( | ( | ( | ( | ( | ||
Administrative expenses | ( | ( | ( | ( | ( | ||
Operating profit | ( | ( | |||||
Financial income | 5 | ||||||
Financial expenses | 5 | ( | ( | ( | ( | ( | ( |
Share of profits of joint ventures | 13 | ||||||
Profit before tax | ( | ( | |||||
Income tax expense | 7 | ( | ( | ( | ( | ( | |
Profit for the year | ( | ( | |||||
| Profit attributable to: | |||||||
Equity shareholders of the parent company | |||||||
Non-controlling interest | 26 | ||||||
Profit for the year | |||||||
pence | pence | pence | pence | pence | pence | ||
Dividend per share arising in respect of the year | 26 | ||||||
Dividend per share paid in the year | 26 | ||||||
Earnings per share (basic and diluted) | 8 | ( | ( |
| Adjusted | Adjusting | Statutory | Adjusted | Adjusting | Statutory | ||
| total | items | total | total | items | total | ||
| 2026 | 2026 | 2026 | 2025 | 2025 | 2025 | ||
| notes | £’000 | £’000 | £’000 | £’000 | £’000 | £’000 | |
Profit for the year | ( | ( | |||||
| Other items recognised directly in equity: | |||||||
Items that will not be reclassified to the Consolidated income statement: | |||||||
| Remeasurement of defined benefit pension scheme | |||||||
assets/liabilities/reimbursement right | 23 | ||||||
| Deferred tax on remeasurement of defined benefit | |||||||
pension scheme assets/liabilities/reimbursement right | ( | ( | ( | ( | |||
Total for items that will not be reclassified | |||||||
Items that may be reclassified to the Consolidated income statement: | |||||||
Exchange differences in translation of overseasoperations | 26 | ( | ( | ( | ( | ||
| Exchange differences in translation of overseas | |||||||
jointventure | 26 | ||||||
Changes in fair value of cash flow hedges | 25,26 | ( | ( | ||||
Deferred tax on changes in fair value of cashflowhedges | 7,26 | ( | ( | ||||
Total for items that may be reclassified | ( | ( | ( | ( | |||
Total other comprehensive income and expense, net of tax | ( | ( | |||||
Total comprehensive income and expense for theyear | ( | ( | |||||
| Attributable to: | |||||||
Equity shareholders of the parent company | |||||||
Non-controlling interest | 26 | ||||||
Total comprehensive income and expense for theyear |
| 2026 | 2025 | ||
| notes | £’000 | £’000 | |
| Non-current assets | |||
Property, plant and equipment | 9 | ||
Right-of-use assets | 10 | ||
Investment properties | 11 | ||
Intangible assets | 12 | ||
Investments in joint ventures | 13 | ||
Finance lease receivables | 14 | ||
Employee benefits | 23 | ||
Reimbursement right | 23 | ||
Deferred tax assets | 7 | ||
Derivatives | 25 | ||
Total non-current assets | |||
| Current assets | |||
Inventories | 16 | ||
Trade receivables | 25 | ||
Finance lease receivables | 14 | ||
Current tax | |||
Other receivables | 25 | ||
Derivatives | 25 | ||
Bank deposits | 15, 25 | ||
Cash and cash equivalents | 15, 25 | ||
Total current assets | |||
| Current liabilities | |||
Trade payables | 25 | ||
Contract liabilities | 18 | ||
Current tax | |||
Provisions | 17 | ||
Derivatives | 25 | ||
Lease liabilities | 21 | ||
Amounts payable to joint venture | 13 | ||
Borrowings | 20 | ||
Other payables | 19 | ||
Total current liabilities | |||
Net current assets | |||
| Non-current liabilities | |||
Lease liabilities | 21 | ||
Borrowings | 20 | ||
Employee benefits | 23 | ||
Deferred tax liabilities | 7 | ||
Derivatives | 25 | ||
Total non-current liabilities | |||
Total assets less total liabilities | |||
| Equity | |||
Share capital | 26 | ||
Share premium | |||
Own shares held | 26 | ( | ( |
Currency translation reserve | 26 | ( | ( |
Cash flow hedging reserve | 26 | ||
Retained earnings | |||
Other reserve | 26 | ( | |
Equity attributable to the shareholders of the parent company | |||
Non-controlling interest | 26 | ( | ( |
Total equity |
| Own | Currency | Cash flow | Non- | ||||||
| Share | Share | shares | translation | hedging | Retained | Other | controlling | ||
| capital | premium | held | reserve | reserve | earnings | reserve | interest | Total | |
| Year ended 30 June 2025 | £’000 | £’000 | £’000 | £’000 | £’000 | £’000 | £’000 | £’000 | £’000 |
Balance at 1 July 2024 | ( | ( | |||||||
Profit for the year | |||||||||
| Other comprehensive income andexpense | |||||||||
| (net of tax) | |||||||||
| Remeasurement of defined benefit pension | |||||||||
schemeassets/liabilities/reimbursement right | |||||||||
Foreign exchange translation differences | ( | ( | |||||||
Foreign exchange related to joint venture | |||||||||
Changes in fair value of cash flow hedges | |||||||||
| Total other comprehensive income | |||||||||
and expense | ( | ||||||||
| Total comprehensive income | |||||||||
and expense | ( | ||||||||
Share-based payments charge | |||||||||
Distribution of own shares | ( | ||||||||
Purchase of own shares | ( | ( | |||||||
Dividends paid | ( | ( | |||||||
Balance at 30 June 2025 | ( | ( | ( | ||||||
| Year ended 30 June 2026 | |||||||||
Profit for the year | |||||||||
| Other comprehensive income andexpense | |||||||||
| (net of tax) | |||||||||
| Remeasurement of defined benefit pension | |||||||||
schemeassets/liabilities/reimbursement right | |||||||||
Foreign exchange translation differences | ( | ( | |||||||
Foreign exchange related to joint venture | |||||||||
Changes in fair value of cash flow hedges | ( | ( | |||||||
| Total other comprehensive income | |||||||||
andexpense | ( | ( | ( | ||||||
| Total comprehensive income | |||||||||
and expense | ( | ( | |||||||
Share-based payments charge | |||||||||
Distribution of own shares | ( | ||||||||
Purchase of own shares | ( | ( | |||||||
Dividends paid | ( | ( | |||||||
Balance at 30 June 2026 | ( | ( | ( | ( |
| 2026 | 2025 | ||
| notes | £’000 | £’000 | |
| Cash flows from operating activities | |||
Profit for the year | |||
| Adjustments for: | |||
Depreciation and impairment of property, plant and equipment, right-of-use assets, andinvestment properties | 9,10,11 | ||
| Loss/(profit) on sale of property, plant and equipment | 9 | ( | |
| Amortisation and impairment of intangible assets | 12 | ||
| Loss on disposal of intangible assets | 12 | ||
| Share of profits from joint ventures | 13 | ( | ( |
| Defined benefit pension schemes service and administrative costs | 23 | ||
| Financial income | 5 | ( | ( |
| Financial expenses | 5 | ||
Fair value gain on acquisition of subsidiary | 30 | ( | |
Share-based payment expense | 24 | ||
| Tax expense | 7 | ||
| (Increase)/decrease in inventories | ( | ||
| Increase in trade, finance lease and other receivables | ( | ( | |
| Increase in trade and other payables | |||
| Increase in provisions | |||
( | |||
| Defined benefit pension scheme contributions | 23 | ( | ( |
| Income taxes paid | ( | ( | |
| Cash flows from operating activities | |||
| Investing activities | |||
| Purchase of property, plant and equipment, and investment properties | 9,11 | ( | ( |
| Sale of property, plant and equipment | |||
| Development costs capitalised | 12 | ( | ( |
| Purchase of other intangibles | 12 | ( | ( |
| Decrease/(increase) in bank deposits | 15 | ( | |
| Interest received | 5 | ||
| Acquisition of a subsidiary, net of cash acquired | 30 | ||
| Dividends received from joint ventures | 13 | ||
| Cash flows from investing activities | ( | ||
| Financing activities | |||
| Repayment of borrowings | 20 | ( | ( |
| Amounts received as deposit from joint venture | 13 | ||
| Interest paid | 5 | ( | ( |
| Repayment of principal of lease liabilities | 22 | ( | ( |
| Own shares purchased | 26 | ( | ( |
| Dividends paid | 26 | ( | ( |
| Cash flows from financing activities | ( | ( | |
| Net increase/(decrease) in cash and cash equivalents | ( | ||
| Cash and cash equivalents at the beginning of the year | |||
| Effect of exchange rate fluctuations on cash held | |||
| Cash and cash equivalents at the end of the year | 15 |
Item | Key judgements (J) and estimates (E) | Page |
Taxation | J – Whether uncertain tax positions need to be recognised | 152 |
Research and development costs | J – Whether a project meets the criteria for capitalisation | 158 |
Capitalised development costs | E – Estimates of future cash flows for impairment testing | 158 |
Inventories | E – Determination of net realisable value | 163 |
Defined benefit pension schemes | E – Valuation of defined benefit pension schemes’ liabilities | 166 |
Defined benefit pension schemes | J – Whether past service costs need to be recognised | 166 |
Adjusted performance measures | J – Whether items are appropriate to exclude from adjusted measures | 180 |
| Industrial | Position | Specialised | ||
| Metrology | Measurement | Technologies | Total | |
| Year ended 30 June 2026 | £’000 | £’000 | £’000 | £’000 |
Revenue | 447,446 | 260,940 | 107,393 | 815,779 |
Depreciation, amortisation and impairment | 20,031 | 18,358 | 3,983 | 42,372 |
Research and development expenditure | 35,906 | 17,911 | 11,298 | 65,115 |
Statutory operating profit | 66,357 | 67,230 | 1,738 | 135,325 |
Cost reduction programme | 9,098 | 3,833 | 1,994 | 14,925 |
Loss of office payable to an Executive Director | 1,244 | 416 | 320 | 1,980 |
Closure of drug delivery business | – | – | 666 | 666 |
Adjusted operating profit | 76,699 | 71,479 | 4,718 | 152,896 |
Share of profits of joint ventures | 432 | 3,608 | – | 4,040 |
Net financial income | – | – | – | 11,018 |
Adjusted profit before tax | – | – | – | 167,954 |
| Industrial | Position | Specialised | ||
| Metrology | Measurement | Technologies | Total | |
| Year ended 30 June 2025 | £’000 | £’000 | £’000 | £’000 |
Revenue | 430,565 | 207,43 0 | 75,049 | 713,044 |
Depreciation, amortisation and impairment | 22,768 | 8,219 | 4,759 | 35,746 |
Research and development expenditure | 41,480 | 17,766 | 9,664 | 68,910 |
Statutory operating profit/(loss) | 74,130 | 46,010 | (12,255) | 107,88 5 |
Closure of drug delivery business | – | – | 2,059 | 2,059 |
Closure of Edinburgh research facility | 1,378 | 618 | 324 | 2,320 |
Adjusted operating profit/(loss) | 75,508 | 46,628 | (9,872) | 112,264 |
Share of profits of joint ventures | 488 | 3,050 | – | 3,538 |
Net financial income | – | – | – | 11,429 |
Adjusted profit before tax | – | – | – | 127,231 |
| 2026 | 2025 | |
| £’000 | £’000 | |
UK | 285,555 | 286,14 5 |
APAC | 35,687 | 38,797 |
EMEA | 91,051 | 86,445 |
Americas | 45,316 | 40,876 |
Total non-current assets | 457,609 | 452,263 |
| 2026 | 2025 | |
| £’000 | £’000 | |
Goods, capital equipment and installation | 739,355 | 642,378 |
Aftermarket services | 76,424 | 70,666 |
Total Group revenue | 815,779 | 713,044 |
| 2026 | 2025 | |
| £’000 | £’000 | |
APAC | 381,911 | 337,721 |
29,986 | 34,017 | |
EMEA, excluding UK | 184,871 | 173,751 |
EMEA | 214,857 | 207,768 |
Americas | 219,011 | 167,555 |
Total Group revenue | 815,779 | 713,044 |
| 2026 | 2025 | |
| £’000 | £’000 | |
China | 220,106 | 186,495 |
USA | 192,912 | 142,860 |
Germany | 59,253 | 55,682 |
Japan | 50,964 | 49,273 |
| 2026 | 2025 | |
| £’000 | £’000 | |
Wages and salaries | 262,976 | 247,070 |
Compulsory social security contributions | 33,129 | 30,514 |
Contributions to defined contribution pension schemes | 30,509 | 29,269 |
Share-based payment charge | 491 | 790 |
Total payroll costs | 327,105 | 307,6 4 3 |
| 2026 | 2025 | |
| Number | Number | |
UK | 3,251 | 3,491 |
Overseas | 1,806 | 1,848 |
Average number of employees | 5,057 | 5,339 |
| 2026 | 2025 | |
| £’000 | £’000 | |
Short-term employee benefits | 9,263 | 6,322 |
Post-employment benefits | 521 | 489 |
Share-based payment charge | 491 | 790 |
Total remuneration of key management personnel | 10,275 | 7,601 |
| Adjusted | Adjusting | Statutory | Adjusted | Adjusting | Statutory | |
| total | items | total | total | items | total | |
| 2026 | 2026 | 2026 | 2025 | 2025 | 2025 | |
| £’000 | £’000 | £’000 | £’000 | £’000 | £’000 | |
Production costs | 329,506 | 2,609 | 332,115 | 272,814 | – | 272,814 |
Research and development expenditure | 61,622 | 3,493 | 65,115 | 68,910 | – | 68,910 |
Other engineering expenditure | 46,171 | 2,617 | 48,788 | 46,770 | 4,379 | 51,149 |
Gross engineering expenditure | 107,793 | 6,110 | 113,903 | 115,680 | 4,379 | 120,059 |
Development expenditure capitalised (net of amortisation) | (5,441) | – | (5,441) | (5,574) | – | (5,574) |
Development expenditure impaired | 3,804 | – | 3,804 | 1,818 | – | 1,818 |
Development expenditure disposed | – | 916 | 916 | – | – | – |
Research and development tax credit | (5,239) | – | (5,239) | (5,088) | – | (5,088) |
Total engineering costs | 100,917 | 7,026 | 107,943 | 106,836 | 4,379 | 111,215 |
Total cost of sales | 430,423 | 9,635 | 440,058 | 379,650 | 4,379 | 384,029 |
| 2026 | 2025 | |
| Financial income | £’000 | £’000 |
Bank interest receivable | 9,419 | 11,741 |
Currency gains | 3,208 | – |
Fair value gains from one-month forward currency contracts | – | 3,360 |
Interest on pension schemes’ assets | 552 | 503 |
Other interest income | 2,450 | 913 |
Total financial income | 15,629 | 16,517 |
| 2026 | 2025 | |
| Financial expenses | £’000 | £’000 |
Currency losses | – | 3,899 |
Fair value losses from one-month forward currency contracts | 895 | – |
Lease interest | 617 | 685 |
Interest payable on amounts owed to joint ventures | 282 | 371 |
Interest on pension schemes’ liabilities | 173 | – |
Interest payable on borrowings | 35 | 49 |
Other interest payable | 3,028 | 4,936 |
Total financial expenses | 5,030 | 9,940 |
| 2026 | 2025 | ||
| notes | £’000 | £’000 | |
Depreciation and impairment of property, plant and equipment, right-of-use assets, and investment properties | 9,10,11 | 33,719 | 29,057 |
Loss/(profit) on sale of property, plant and equipment | 9 | 107 | (1,083) |
Amortisation and impairment of intangible assets | 12 | 8,653 | 6,689 |
Loss on disposal of intangible assets | 12 | 1,017 | – |
Fair value gain on acquisition of subsidiary | 30 | (359) | – |
Grant income | – | (2,001) | (3,280) |
| 2026 | 2025 | |
| £’000 | £’000 | |
Audit of these financial statements | 985 | 899 |
Audit of subsidiary undertakings pursuant to legislation | 606 | 589 |
Other assurance | – | – |
All other non-audit fees | 46 | 33 |
Total auditor fees | 1,637 | 1,521 |
| 2026 | 2025 | |
| £’000 | £’000 | |
| Current tax: | ||
UK corporation tax on profits for the year | 15,022 | 7,550 |
UK corporation tax – prior year adjustments | (2,324) | 2,778 |
Overseas tax on profits for the year | 18,612 | 16,018 |
Overseas tax – prior year adjustments | (376) | 6,166 |
Global minimum tax | 803 | 757 |
Total current tax | 31,737 | 33,269 |
| Deferred tax: | ||
Origination and reversal of temporary differences | (667) | 2,077 |
Prior year adjustments | 81 | (1,203) |
Derecognition of previously recognised tax losses and excess interest | 202 | 323 |
Recognition of previously unrecognised tax losses and excess interest | (349) | (223) |
(733) | 974 | |
Tax charge on profit | 31,004 | 34,243 |
| 2026 | 2025 | |
| £’000 | £’000 | |
Profit before tax | 149,964 | 118,000 |
Tax at 25.0% (2025: 25.0%) | 37,491 | 29,500 |
| Effects of: | ||
Different tax rates applicable in overseas subsidiaries | (5,800) | (4,648) |
Permanent differences | 1,493 | 1,439 |
Global minimum tax | 803 | 757 |
Companies with unrelieved tax losses | 29 | 7 |
Share of profits of joint ventures | (1,010) | (885) |
Tax incentives | (7) | (123) |
Prior year adjustments | (2,619) | 7,741 |
Recognition of previously unrecognised tax losses and excess interest | (349) | (223) |
Derecognition of previously recognised tax losses and excess interest | 202 | 323 |
Irrecoverable withholding tax | 286 | 720 |
Deferred tax on unremitted earnings | 471 | (425) |
Other differences | 14 | 60 |
Tax charge on profit | 31,004 | 34,243 |
Effective tax rate | 20.7% | 29.0% |
2026 | 2025 | |||||
| Assets | Liabilities | Net | Assets | Liabilities | Net | |
| £’000 | £’000 | £’000 | £’000 | £’000 | £’000 | |
Property, plant and equipment | 1,023 | (35,336) | (34,313) | 574 | (33,086) | (32,512) |
Intangible assets | – | (5,071) | (5,071) | – | (4,655) | (4,655) |
Intragroup trading (inventories) | 20,470 | – | 20,470 | 16,262 | – | 16,262 |
Intragroup trading (fixed assets) | 1,143 | – | 1,143 | 1,12 9 | – | 1,129 |
Defined benefit pension schemes | 5,671 | (2,345) | 3,326 | 6,128 | (2,380) | 3,748 |
Reimbursement right | – | (4,224) | (4,224) | – | (3,744) | (3,744) |
Derivatives | – | (2,036) | (2,036) | – | (5,088) | (5,088) |
Tax losses | 1,156 | – | 1,156 | 1,545 | – | 1,545 |
Other | 7,110 | (1,653) | 5,457 | 7,66 3 | (700) | 6,963 |
Balance at the end of the year | 36,573 | (50,665) | (14,092) | 33,301 | (49,653) | (16,352) |
| 2026 | 2025 | |
| £’000 | £’000 | |
Balance at the beginning of the year | (16,352) | (13,233) |
Movements in relation to property, plant and equipment | (1,801) | (3,115) |
Movements in relation to intangible assets | (416) | (588) |
Movements in relation to intragroup trading (inventories) | 4,208 | 1,115 |
Movements in relation to intragroup trading (fixed assets) | 14 | 28 |
Movements in relation to defined benefit pension scheme assets/liabilities/reimbursement right | 713 | 146 |
Movements in relation to tax losses | (389) | (278) |
Movements in relation to other | (1,596) | 1,718 |
Movements in the Consolidated income statement | 733 | (974) |
Movements in relation to the cash flow hedging reserve | 3,052 | (1,451) |
Movements in relation to the defined benefit pension scheme assets/liabilities/reimbursement right | (1,615) | (374) |
Movements in the Consolidated statement of comprehensive income and expense | 1,437 | (1,825) |
Currency adjustment | 90 | (320) |
Balance at the end of the year | (14,092) | (16,352) |
2026 | 2025 | |
Statutory profit after tax attributable to shareholders (£’000) | 118,9 60 | 83,757 |
Number of shares (72,788,543 allotted, called-up and fully paid ordinary shares) | 72 ,757,446 | 72,734,797 |
Basic earnings per share | 163.5p | 115.2p |
Diluted earnings per share | 163.5p | 115.2p |
| Freehold | Assets in the | ||||
| land and | Plant and | Motor | course of | ||
| buildings | equipment | vehicles | construction | Total | |
| Year ended 30 June 2026 | £’000 | £’000 | £’000 | £’000 | £’000 |
| Cost | |||||
At 1 July 2025 | 274,628 | 309,054 | 5,962 | 34,539 | 624,183 |
Additions | 4,088 | 23,492 | 580 | 10,182 | 38,342 |
Acquisition of a subsidiary | 1,466 | 289 | 51 | – | 1,806 |
Transfers | 24,892 | 7,175 | – | (32,067) | – |
Transfers to Investment properties | (14,090) | (453) | – | – | (14,543) |
Disposals | (1,735) | (31,057) | (1,187) | – | (33,979) |
Currency adjustment | 411 | 1,039 | 62 | – | 1,512 |
At 30 June 2026 | 289,660 | 309,539 | 5,468 | 12,654 | 617, 321 |
| Depreciation | |||||
At 1 July 2025 | 53,790 | 227,715 | 4,391 | – | 285,896 |
Charge for the year | 5,463 | 17,5 63 | 446 | – | 23,472 |
Acquisition of a subsidiary | 134 | 276 | 38 | – | 448 |
Impairment | – | 1,500 | – | – | 1,500 |
Transfers to Investment properties | (2,692) | (322) | – | – | (3,014) |
Disposals | (170) | (28,818) | (999) | – | (29,987) |
Currency adjustment | 369 | 668 | 22 | – | 1,059 |
At 30 June 2026 | 56,894 | 218,582 | 3,898 | – | 279,374 |
| Net book value | |||||
At 30 June 2026 | 232,766 | 90,957 | 1,570 | 12,654 | 337,947 |
At 30 June 2025 | 220,838 | 81,339 | 1,571 | 34,539 | 338,287 |
| Freehold | Assets in the | ||||
| land and | Plant and | Motor | course of | ||
| buildings | equipment | vehicles | construction | Total | |
| Year ended 30 June 2025 | £’000 | £’000 | £’000 | £’000 | £’000 |
| Cost | |||||
At 1 July 2024 | 255,536 | 278,189 | 6,099 | 56,593 | 596,417 |
Additions | 6,374 | 23,258 | 1,220 | 15,421 | 46,273 |
Transfers | 19,032 | 18,443 | – | (37,475) | – |
Transfers to Investment properties | (2,795) | (597) | – | – | (3,392) |
Disposals | (725) | (7,819) | (1,206) | – | (9,750) |
Currency adjustment | (2,794) | (2,420) | (151) | – | (5,365) |
At 30 June 2025 | 274,628 | 309,054 | 5,962 | 34,539 | 624,183 |
| Depreciation | |||||
At 1 July 2024 | 49,460 | 216,838 | 5,079 | – | 271,377 |
Charge for the year | 5,275 | 17,497 | 470 | – | 23,242 |
Impairment | 989 | – | – | – | 989 |
Transfers to Investment properties | (1,179) | (439) | – | – | (1,618) |
Disposals | (270) | (4,619) | (1,057) | – | (5,946) |
Currency adjustment | (485) | (1,562) | (101) | – | (2,148) |
At 30 June 2025 | 53,790 | 227,715 | 4,391 | – | 285,896 |
| Net book value | |||||
At 30 June 2025 | 220,838 | 81,339 | 1,571 | 34,539 | 338,287 |
At 30 June 2024 | 206,076 | 61,351 | 1,020 | 56,593 | 325,040 |
| Leasehold | Plant and | Motor | ||
| property | equipment | vehicles | Total | |
| Year ended 30 June 2026 | £’000 | £’000 | £’000 | £’000 |
| Net book value | ||||
At 1 July 2025 | 8,653 | 74 | 3,491 | 12,218 |
Additions | 564 | 7 | 2,870 | 3,441 |
Depreciation | (2,316) | (39) | (2,642) | (4,997) |
Currency adjustment | 256 | 1 | 47 | 304 |
At 30 June 2026 | 7,157 | 43 | 3,766 | 10,966 |
| Leasehold | Plant and | Motor | ||
| property | equipment | vehicles | Total | |
| Year ended 30 June 2025 | £’000 | £’000 | £’000 | £’000 |
| Net book value | ||||
At 1 July 2024 | 9,899 | 66 | 4,781 | 14,746 |
Additions | 1,746 | 49 | 841 | 2,636 |
Reductions | – | – | (12) | (12) |
Depreciation | (2,541) | (43) | (2,049) | (4,633) |
Currency adjustment | (451) | 2 | (70) | (519) |
At 30 June 2025 | 8,653 | 74 | 3,491 | 12,218 |
| 2026 | 2025 | |
| £’000 | £’000 | |
| Cost | ||
Balance at the beginning of the year | 15,211 | 12,103 |
Transfers from Property, plant and equipment | 14,543 | 3,392 |
Acquisition of a subsidiary | 350 | – |
Currency adjustment | (109) | (284) |
Balance at the end of the year | 29,995 | 15,211 |
| Depreciation | ||
Balance at the beginning of the year | 3,645 | 1,818 |
Charge for the year | 247 | 193 |
Transfers from Property, plant and equipment | 3,014 | 1,618 |
Impairment | 3,503 | – |
Currency adjustment | 3 | 16 |
Balance at the end of the year | 10,412 | 3,645 |
Net book value | 19,583 | 11,566 |
| 2026 | 2025 | |
| £’000 | £’000 | |
Rental income | 1,249 | 945 |
Direct operating expenses (including repairs and maintenance) | (334) | (218) |
Profit | 915 | 727 |
| Internally | Intellectual | ||||
| generated | property and | ||||
| development | Software | other intangible | |||
| Goodwill | costs | licences | assets | Total | |
| Year ended 30 June 2026 | £’000 | £’000 | £’000 | £’000 | £’000 |
| Cost | |||||
At 1 July 2025 | 19,882 | 189,572 | 12,505 | 4,879 | 226,838 |
Additions | 1,095 | 9,896 | 7 | 43 | 11,041 |
Disposals | – | (19,038) | (3,637) | – | (22,675) |
Currency adjustment | 278 | – | (40) | 6 | 244 |
At 30 June 2026 | 21,255 | 180,430 | 8,835 | 4,928 | 215,448 |
| Amortisation | |||||
At 1 July 2025 | 9,028 | 152,407 | 11,956 | 2,897 | 176,288 |
Charge for the year | – | 4,455 | 179 | 215 | 4,849 |
Impairment | – | 3,804 | – | – | 3,804 |
Disposals | – | (18,122) | (3,536) | – | (21,658) |
Currency adjustment | – | – | (41) | (18) | (59) |
At 30 June 2026 | 9,028 | 142,544 | 8,558 | 3,094 | 163,224 |
| Net book value | |||||
At 30 June 2026 | 12,227 | 37,886 | 277 | 1,834 | 52,224 |
At 30 June 2025 | 10,854 | 37,165 | 549 | 1,982 | 50,550 |
| Internally | Intellectual | ||||
| generated | property and other | ||||
| development | Software | intangible | |||
| Goodwill | costs | licences | assets | Total | |
| Year ended 30 June 2025 | £’000 | £’000 | £’000 | £’000 | £’000 |
| Cost | |||||
At 1 July 2024 | 20,258 | 187,941 | 12,197 | 4,864 | 225,260 |
Additions | – | 9,999 | 286 | – | 10,285 |
Disposals | – | (8,368) | – | – | (8,368) |
Currency adjustment | (376) | – | 22 | 15 | (339) |
At 30 June 2025 | 19,882 | 189,572 | 12,505 | 4,879 | 226,838 |
| Amortisation | |||||
At 1 July 2024 | 9,028 | 154,531 | 11,751 | 2,607 | 177,917 |
Charge for the year | – | 4,426 | 191 | 254 | 4,871 |
Impairment | – | 1,818 | – | – | 1,818 |
Disposals | – | (8,368) | – | – | (8,368) |
Currency adjustment | – | – | 14 | 36 | 50 |
At 30 June 2025 | 9,028 | 152,407 | 11,956 | 2,897 | 176,288 |
| Net book value | |||||
At 30 June 2025 | 10,854 | 37,165 | 549 | 1,982 | 50,550 |
At 30 June 2024 | 11,230 | 33,410 | 446 | 2,257 | 47,3 4 3 |
| 2026 | 2025 | |
| £’000 | £’000 | |
Industrial Metrology (IM) | 10,008 | n/a |
Neurological (NPD) | 2,219 | n/a |
Total goodwill | 12,227 | 10,854 |
| 2026 | 2025 | |||
| 2026 | Long-term | 2025 | Long-term | |
| CGU | Discount rate | growth rate | Discount rate | growth rate |
Industrial Metrology (IM) | 15.8% | 0.0% | n/a | n/a |
Neurological (NPD) | 22.4% | 0.0% | n/a | n/a |
| Country of incorporation and | 2026 | 2025 | |
| principal place of business | Ownership % | Ownership % | |
RLS Merilna tehnika d.o.o. (RLS) – joint venture | Slovenia | 50.0 | 50.0 |
Metrology Software Products Limited (MSP) – joint venture | England & Wales | 100.0 | 70.0 |
| 2026 | 2025 | |
| £’000 | £’000 | |
Balance at the beginning of the year | 27,692 | 25,485 |
Dividends received | (957) | (1,500) |
Share of profits of joint ventures | 4,040 | 3,538 |
Acquisition of subsidiary | (4,840) | – |
Currency adjustment | 190 | 169 |
Balance at the end of the year | 26,125 | 27,6 92 |
RLS | MSP | |||
| 2026 | 2025 | 2026 | 2025 | |
| £’000 | £’000 | £’000 | £’000 | |
Assets | 58,795 | 52,093 | – | 6,258 |
Liabilities | (6,546) | (5,526) | – | (532) |
Net assets | 52,249 | 46,567 | – | 5,726 |
Group’s share of net assets | 26,125 | 23,284 | – | 4,008 |
Revenue | 44,885 | 38,045 | 3,431 | 3,389 |
Profit for the year | 7,216 | 6,10 0 | 617 | 697 |
Group’s share of profit for the year | 3,608 | 3,050 | 432 | 488 |
2026 | 2025 | |||||
| Gross | Net | Gross | Net | |||
| investment | Interest | investment | investment | Interest | investment | |
| £’000 | £’000 | £’000 | £’000 | £’000 | £’000 | |
Receivable in less than one year | 8,253 | 1,066 | 7,187 | 6,027 | 832 | 5,19 5 |
Receivable between one and two years | 7,812 | 951 | 6,861 | 5,416 | 572 | 4,844 |
Receivable between two and three years | 3,689 | 271 | 3,418 | 4,120 | 317 | 3,803 |
Receivable between three and four years | 417 | 16 | 401 | 2,669 | 154 | 2,515 |
Receivable between four and five years | 87 | 3 | 84 | 803 | 15 | 788 |
Total future minimum lease payments receivable | 20,258 | 2,307 | 17,951 | 19,035 | 1,890 | 17,145 |
| 2026 | 2025 | |
| £’000 | £’000 | |
Receivable in less than one year | 1,508 | 1,13 8 |
Receivable in more than one year | 2,580 | 1,323 |
Total future minimum lease payments receivable | 4,088 | 2,461 |
| 2026 | 2025 | |
| £’000 | £’000 | |
Bank balances and cash in hand | 148,092 | 87,138 |
Short-term deposits | 209 | 282 |
Balance at the end of the year | 148,301 | 87,420 |
| 2026 | 2025 | |
| £’000 | £’000 | |
Raw materials | 62,440 | 56,911 |
Work in progress | 37,758 | 31,623 |
Finished goods | 81,545 | 70,931 |
Balance at the end of the year | 181,743 | 159,465 |
Warranty | Other | |||
| 2026 | 2025 | 2026 | 2025 | |
| £’000 | £’000 | £’000 | £’000 | |
Balance at the beginning of the year | 2,826 | 2,997 | 6,152 | – |
Created during the year | 2,783 | 3,281 | 3,505 | 6,152 |
Unused amounts reversed | – | (924) | (2,450) | – |
Utilised in the year | (1,928) | (2,528) | (1,300) | – |
855 | (171) | (245) | 6,152 | |
Balance at the end of the year | 3,681 | 2,826 | 5,907 | 6,152 |
| 2026 | 2025 | |
| £’000 | £’000 | |
Goods, capital equipment and installation | 2,087 | 813 |
Aftermarket services | 9,405 | 8,251 |
Deferred revenue | 11,492 | 9,064 |
Advances received from customers | 14,819 | 5,605 |
Balance at the end of the year | 26,311 | 14,669 |
| 2026 | 2025 | |
| £’000 | £’000 | |
Payroll taxes and social security | 7,905 | 7,484 |
Performance bonuses | 18,055 | 11,047 |
Holiday pay and retirement accruals | 5,792 | 11,091 |
Indirect tax payable | 6,548 | 5,278 |
Deferred research and development tax credit (RDEC) | 2,473 | 1,131 |
Tariff refund payable | 5,680 | – |
Other creditors and accruals | 21,547 | 21,101 |
Total other payables | 68,000 | 57,132 |
| 2026 | 2025 | |
| £’000 | £’000 | |
Balance at the beginning of the year | 2,884 | 3,522 |
Interest | 35 | 49 |
Repayments | (731) | (794) |
Currency adjustment | (202) | 107 |
Balance at the end of the year | 1,986 | 2,884 |
| Leasehold | Plant and | Motor | ||
| property | equipment | vehicles | Total | |
| 2026 | £’000 | £’000 | £’000 | £’000 |
Due in less than one year | 2,431 | 18 | 2,259 | 4,708 |
Due between one and two years | 1,913 | 13 | 1,218 | 3,144 |
Due between two and three years | 1,220 | 11 | 495 | 1,726 |
Due between three and four years | 219 | 4 | 159 | 382 |
Due between four and five years | 104 | – | 6 | 110 |
Due in more than five years | 4,275 | – | – | 4,275 |
Total future minimum lease payments payable | 10,162 | 46 | 4,137 | 14,345 |
Effect of discounting | (2,611) | (2) | (214) | (2,827) |
Lease liabilities | 7,5 51 | 44 | 3,923 | 11,518 |
| Leasehold | Plant and | Motor | ||
| property | equipment | vehicles | Total | |
| 2025 | £’000 | £’000 | £’000 | £’000 |
Due in less than one year | 2,490 | 34 | 1,985 | 4,509 |
Due between one and two years | 2,110 | 18 | 1,303 | 3,431 |
Due between two and three years | 1,667 | 12 | 501 | 2,180 |
Due between three and four years | 1,135 | 11 | 80 | 1,226 |
Due between four and five years | 182 | 4 | 2 | 188 |
Due in more than five years | 4,358 | – | – | 4,358 |
Total future minimum lease payments payable | 11,942 | 79 | 3,871 | 15,892 |
Effect of discounting | (2,916) | (4) | (211) | (3,131) |
Lease liabilities | 9,026 | 75 | 3,660 | 12,761 |
| 2026 | 2025 | |
| £’000 | £’000 | |
Depreciation of right-of-use assets | 4,997 | 4,633 |
Interest expense on lease liabilities | 617 | 685 |
Expenses relating to short-term and low-value leases | 76 | 395 |
Total expense recognised in the Consolidated income statement | 5,690 | 5,713 |
Total cash outflows for leases | 5,653 | 5,364 |
£’000 | 1 July 2025 | Cash flows | Other | Currency | 30 June 2026 |
Lease liabilities | 12,761 | (4,960) | 3,388 | 329 | 11,518 |
Borrowings | 2,884 | (731) | 35 | (202) | 1,986 |
Amounts payable to joint venture | 14,530 | 1,022 | 282 | 114 | 15,948 |
30,175 | (4,669) | 3,705 | 241 | 29,452 |
£’000 | 1 July 2024 | Cash flows | Other | Currency | 30 June 2025 |
Lease liabilities | 15,022 | (4,284) | 2,564 | (541) | 12,761 |
Borrowings | 3,522 | (794) | 49 | 107 | 2,884 |
Amounts payable to joint venture | 8,475 | 5,612 | 371 | 72 | 14,530 |
27,019 | 534 | 2,984 | (362) | 30,175 |
30 June 2026 | 30 June 2025 | |||||
| UK | Ireland | Germany | UK | Ireland | Germany | |
| scheme | scheme | scheme | scheme | scheme | scheme | |
Discount rate | 5.90% | 4.30% | 4.40% | 5.55% | 4.00% | 3.90% |
Rate of increase in pension payments | 2.85% | 2.25% | 2.30% | 2.85% | 2.25% | 2.00% |
Rate of increase in salary | n/a | n/a | 2.80% | n/a | n/a | 2.50% |
Inflation rate (RPI) | 3.05% | 2.25% | n/a | 3.05% | 2.25% | n/a |
2.05% 1 | 2.05% 1 | |||||
| Inflation rate (CPI) | 3.05% 2 | 2.25% | 2.30% | 3.05% 2 | 2.25% | 2.00% |
Retirement age | 65 | 65 | 67 | 65 | 65 | 67 |
Scheme duration | 14 | 22 | 17 | 15 | 22 | 19 |
30 June 2026 | 30 June 2025 | |||||
| UK | Ireland | Germany | UK | Ireland | Germany | |
| scheme | scheme | scheme | scheme | scheme | scheme | |
Male currently aged 65 | 22.3 | 21.7 | n/a | 21.1 | 21.0 | n/a |
Female currently aged 65 | 24.5 | 24.0 | n/a | 23.5 | 23.5 | n/a |
| Male currently aged 45 | 23.0 | 22.7 | n/a | 21.8 | 21.9 | n/a |
Female currently aged 45 | 25.3 | 25.1 | n/a | 24.4 | 24.6 | n/a |
| 30 June | % of | 30 June | % of | |
| 2026 | total | 2025 | total | |
| £’000 | assets | £’000 | assets | |
| Market value of assets: | ||||
Insurance contract | 127,680 | 81 | 118,158 | 83 |
Index-linked gilts | 8,709 | 6 | 5,815 | 4 |
Credit and fixed income funds | 7,635 | 5 | 7,924 | 6 |
Equities | 5,614 | 4 | 4,295 | 3 |
Multi-asset funds | 4,582 | 3 | 4,640 | 3 |
Cash and other | 3,712 | 1 | 781 | 1 |
157,932 | 100 | 141,613 | 100 | |
Actuarial value of liabilities | (166,005) | – | (151,301) | – |
Deficit in the schemes | (8,073) | – | (9,688) | – |
Deferred tax thereon | 3,326 | – | 3,748 | – |
| Reimbursement | ||||
| right | Assets | Liabilities | Total | |
| Year ended 30 June 2026 | £’000 | £’000 | £’000 | £’000 |
Balance at the beginning of the year | 12,909 | 141,613 | (151,301) | 3,221 |
Transfers in | – | 1,300 | (6,520) | (5,220) |
Contributions paid by employer | 1,769 | 1,090 | – | 2,859 |
Contributions paid by employee | – | 68 | (68) | – |
Current service cost | – | – | (1,160) | (1,160) |
Past service cost | – | – | (202) | (202) |
Interest on pension schemes | 502 | 7,586 | (7,709) | 379 |
Remeasurement gain/(loss) under IAS 19 | (325) | 14,622 | (6,605) | 7,692 |
Scheme administration expenses | – | (1,076) | – | (1,076) |
Benefits paid | (289) | (7, 271) | 7,560 | – |
Balance at the end of the year | 14,566 | 157,932 | (166,005) | 6,493 |
| Reimbursement | ||||
| right | Assets | Liabilities | Total | |
| Year ended 30 June 2025 | £000 | £’000 | £’000 | £’000 |
Balance at the beginning of the year | 12,116 | 153,134 | (163,638) | 1,612 |
Contributions paid | – | 162 | – | 162 |
Interest on pension schemes | – | 7,4 65 | (6,962) | 503 |
Remeasurement gain/(loss) under IAS 19 | 1,498 | (12,267) | 13,546 | 2,777 |
Scheme administration expenses | (705) | (1,128) | – | (1,833) |
Benefits paid | – | (5,753) | 5,753 | – |
Balance at the end of the year | 12,909 | 141,613 | (151,301) | 3,221 |
| 2026 | 2025 | |
| £’000 | £’000 | |
| Actuarial gain/(loss) arising from: | ||
Changes in demographic assumptions | (2,887) | – |
Changes in financial assumptions | 9,057 | 14,857 |
Experience adjustment | (12,775) | 187 |
Return on plan assets excluding interest income | 13,961 | (12,267) |
Adjustment for the asset ceiling | 336 | – |
Total amount recognised in the Consolidated statement of comprehensive income and expense | 7,692 | 2,777 |
Approximate effect on liabilities | UK scheme | Ireland scheme | Germany scheme |
Discount rate: Increase/decrease by 0.5% | -£9.3m/+£10.3m | -£1.1m/+£1.3m | -£1.1m/+£1.2m |
Inflation: Increase/decrease by 0.5% | +£8.0m/-£6.9m | +£1.3m/-£1.1m | +£0.9m/-£0.8m |
Mortality: Increased/decreased life by one year | +£3.9m/-£4.0m | +£0.3m/-£0.4m | n/a |
| Trade and finance | Cash and cash equivalents | |||||
lease receivables | Other receivables | and bank deposits | ||||
| 2026 | 2025 | 2026 | 2025 | 2026 | 2025 | |
| Currency | £’000 | £’000 | £’000 | £’000 | £’000 | £’000 |
Pound Sterling | 15,788 | 17,076 | 29,650 | 30,438 | 229,882 | 223,491 |
US Dollar | 84,894 | 50,034 | 9,975 | 970 | 9,235 | 11,322 |
Euro | 32,764 | 30,669 | 3,712 | 3,525 | 21,784 | 5,153 |
Chinese Yuan | 11,910 | 13,592 | 1,001 | 512 | 14,741 | 17,069 |
Japanese Yen | 8,992 | 13,181 | 81 | 136 | 4,788 | 2,730 |
Other | 25,157 | 21,057 | 5,533 | 5,151 | 10,520 | 13,881 |
179,505 | 145,609 | 49,952 | 40,732 | 290,950 | 273,646 |
| 2026 | 2025 | |
| £’000 | £’000 | |
Past due zero to one month | 20,155 | 13,601 |
Past due one to two months | 9,039 | 5,935 |
Past due more than two months | 10,421 | 8,538 |
Balance at the end of the year | 39,615 | 28,074 |
| 2026 | 2025 | |
| £’000 | £’000 | |
Balance at the beginning of the year | 5,894 | 4,479 |
Changes in amounts provided | 5,015 | 3,215 |
Amounts used | (452) | (1,800) |
Balance at the end of the year | 10,457 | 5,894 |
| Risk category 1 | Risk category 2 | Risk category 3 | Risk category 4 | Risk category 5 | 2026 | Total | |
| Year ended 30 June 2026 | £’000 | £’000 | £’000 | £’000 | £’000 | £’000 | |
Gross trade receivables | 15,016 | 44,558 | 105,987 | 5,749 | 701 | 172,011 | |
Expected credit loss rate | 0.79% | 0.86% | 0.93% | 1.00% | 1.07% | 0.89% | |
Expected credit loss allowance | 119 | 382 | 968 | 57 | 7 | 1,533 | |
Specific loss allowance | 6 | – | 7, 352 | 1,566 | – | 8,924 | |
Total loss allowance | 125 | 382 | 8,320 | 1,623 | 7 | 10,457 | |
Net trade receivables | 14,891 | 44,176 | 97,667 | 4,126 | 694 | 161,554 |
| Risk category 1 | Risk category 2 | Risk category 3 | Risk category 4 | Risk category 5 | 2025 | Total | |
| Year ended 30 June 2025 | £’000 | £’000 | £’000 | £’000 | £’000 | £’000 | |
Gross trade receivables | 14,397 | 31,663 | 82,780 | 5,518 | – | 134,358 | |
Expected credit loss rate | 0.55% | 0.61% | 0.66% | 0.71% | – | 0.65% | |
Expected credit loss allowance | 80 | 192 | 531 | 39 | – | 842 | |
Specific loss allowance | – | – | 4,730 | 322 | – | 5,052 | |
Total loss allowance | 80 | 192 | 5,261 | 361 | – | 5,894 | |
Net trade receivables | 14,317 | 31,471 | 77,519 | 5,157 | – | 128,464 |
| 2026 | 2025 | |
| £’000 | £’000 | |
Indirect tax receivable | 13,403 | 10,959 |
Software maintenance | 9,238 | 10,181 |
Bank interest receivable | 3,436 | 4,790 |
Tariff refund receivable | 8,556 | – |
Grants | 1,130 | 885 |
Research and development tax credit recoverable | 263 | 1,224 |
Contract assets | 2,523 | 1,509 |
Other prepayments | 11,403 | 11,18 4 |
Total other receivables | 49,952 | 40,732 |
| 2026 | 2025 | |
| £’000 | £’000 | |
Receivable between one and two years | 1,652 | 7,878 |
1,652 | 7,878 |
| Contractual cash flows | ||||||
| Carrying | Effect of | Gross | ||||
| amount | discounting | maturities | Up to 1 year | 1-2 years | 3-5 years | |
| Year ended 30 June 2026 | £’000 | £’000 | £’000 | £’000 | £’000 | £’000 |
Trade payables | 38,238 | – | 38,238 | 38,238 | – | – |
Other payables | 68,000 | – | 68,000 | 68,000 | – | – |
Borrowings | 1,986 | 44 | 2,030 | 694 | 684 | 652 |
Amounts payable to joint venture | 15,948 | – | 15,948 | 15,948 | – | – |
Lease liabilities | 11,518 | 2,827 | 14,345 | 4,708 | 3,144 | 6,493 |
Forward exchange contracts | 1,113 | – | 1,113 | 1,073 | 40 | – |
136,803 | 2,871 | 139,674 | 128,661 | 3,868 | 7,14 5 |
| Contractual cash flows | ||||||
| Carrying | Effect of | Gross | ||||
| amount | discounting | maturities | Up to 1 year | 1-2 years | 3-5 years | |
| Year ended 30 June 2025 | £’000 | £’000 | £’000 | £’000 | £’000 | £’000 |
Trade payables | 25,943 | – | 25,943 | 25,943 | – | – |
Other payables | 57,132 | – | 57,132 | 57,132 | – | – |
Borrowings | 2,884 | 85 | 2,969 | 764 | 754 | 1,451 |
Amounts payable to joint venture | 14,530 | – | 14,530 | 14,530 | – | – |
Lease liabilities | 12,761 | 3,131 | 15,892 | 4,509 | 3,431 | 7,952 |
Forward exchange contracts | 1,246 | – | 1,246 | 150 | 1,096 | – |
114,496 | 3,216 | 117,712 | 103,028 | 5,281 | 9,403 |
2026 | 2025 | |||
| Nominal value | Fair value | Nominal value | Fair value | |
| £’000 | £’000 | £’000 | £’000 | |
US Dollar | 340,768 | 3,786 | 299,987 | 18,954 |
Euro | 152,143 | 2,258 | 146,500 | 613 |
Japanese Yen | 12,956 | 1,582 | 21,947 | 1,354 |
Canadian Dollar | 4,670 | 63 | 5,133 | 56 |
510,537 | 7,689 | 473,567 | 20,977 |
2026 | 2025 | |||||
| Average | Year end | Average | Average | Year end | Average | |
| forward | exchange | exchange | forward | exchange | exchange | |
| Currency | contract rate | rate | rate | contract rate | rate | rate |
US Dollar | 1.27 | 1.32 | 1.34 | 1.28 | 1.37 | 1.30 |
Euro | 1.14 | 1.16 | 1.15 | 1.14 | 1.17 | 1.19 |
Chinese Renminbi | n/a | 9.00 | 9.33 | n/a | 9.80 | 9.35 |
Hong Kong Dollar | n/a | 10.37 | 10.45 | n/a | 10.75 | 10.12 |
Japanese Yen | 175 | 215 | 207 | 178 | 198 | 193 |
Canadian Dollar | n/a | 1.88 | 1.85 | n/a | 1.87 | 1.82 |
2026 | 2025 | |||
| Nominal value | Fair value | Nominal value | Fair value | |
| £’000 | £’000 | £’000 | £’000 | |
| Forward currency contracts in a designated cash flow hedge (i) | ||||
Non-current derivative assets | 171,644 | 1,652 | 137,417 | 7,878 |
Current derivative assets | 243,654 | 6,952 | 218,870 | 13,606 |
Current derivative liabilities | 2,863 | (419) | 19,339 | (37) |
Non-current derivative liabilities | 11,180 | (40) | 33,559 | (1,096) |
429,341 | 8,145 | 409,185 | 20,351 | |
(Losses)/gains recognised in the Consolidated statement of comprehensive income and expense | – | (12,208) | – | 5,804 |
| Forward currency contracts not in a designated cash flow hedge (ii) | ||||
Current derivative assets | 27, 253 | 198 | 56,873 | 739 |
Current derivative liabilities | 53,943 | (654) | 7,509 | (113) |
81,196 | (456) | 64,382 | 626 | |
(Losses)/gains recognised in Financial income/(expense) in the Consolidated income statement | – | (895) | – | 3,360 |
| Total forward contracts and options | ||||
Non-current derivative assets | 171,644 | 1,652 | 137,417 | 7,878 |
Current derivative assets | 270,907 | 7,150 | 275,743 | 14,345 |
Current derivative liabilities | 56,806 | (1,073) | 26,848 | (150) |
Non-current derivative liabilities | 11,180 | (40) | 33,559 | (1,096) |
510,537 | 7,689 | 473,567 | 20,977 |
| 2026 | 2025 | ||
| £’000 | £’000 | ||
72,788,543 | allotted, called-up and fully paid ordinary shares of 20p each | 14,558 | 14,558 |
| 2026 | 2025 | |
| £’000 | £’000 | |
FY2025 final dividend paid of 61.3p per share (2024: 59.4p) | 44,619 | 43,205 |
Interim dividend paid of 16.8p per share (2025: 16.8p) | 12,223 | 12,219 |
Total dividends paid | 56,842 | 55,424 |
| 2026 | 2025 | |
| £’000 | £’000 | |
Balance at the beginning of the year | (2,140) | (2,963) |
Acquisition of own shares | (979) | (154) |
Disposal of own shares on vesting of awards | 2,025 | 977 |
Balance at the end of the year | (1,094) | (2,140) |
| 2026 | 2025 | |
| £’000 | £’000 | |
Balance at the beginning of the year | 1,193 | 1,380 |
Disposal of own shares on vesting of awards | (2,025) | (977) |
Share-based payments charge in respect of awards | 491 | 790 |
Balance at the end of the year | (341) | 1,193 |
| 2026 | 2025 | |
| £’000 | £’000 | |
Balance at the beginning of the year | (3,646) | 2,480 |
Loss on net assets of foreign currency operations | (473) | (6,295) |
Loss in the year relating to subsidiaries | (473) | (6,295) |
Currency exchange differences relating to joint ventures | 190 | 169 |
Balance at the end of the year | (3,929) | (3,646) |
| 2026 | 2025 | |
| £’000 | £’000 | |
Balance at the beginning of the year | 15,264 | 10,911 |
Gain on contract maturity recognised in revenue during the year | (11,315) | 19,176 |
Revaluations during the year | (893) | (13,372) |
Deferred tax movement | 3,052 | (1,451) |
Balance at the end of the year | 6,108 | 15,264 |
| 2026 | 2025 | |
| £’000 | £’000 | |
Balance at the beginning of the year | (577) | (577) |
Balance at the end of the year | (577) | (577) |
| 2026 | 2025 | |
| £’000 | £’000 | |
Freehold land and buildings | 9,312 | 13,856 |
Plant and equipment | 11,015 | 6,411 |
Motor vehicles | 124 | 129 |
Total committed capital expenditure | 20,451 | 20,396 |
| 2026 | 2025 | |
| £’000 | £’000 | |
Purchased goods and services from the Group during the year | 906 | 219 |
Sold goods and services to the Group during the year | 27,425 | 22,794 |
Interest paid from the Group during the year | 282 | 371 |
Paid dividends to the Group during the year | 957 | 1,500 |
Amounts owed to the Group at the year end | 210 | 223 |
Amounts owed by the Group at the year end | 19,638 | 17,462 |
| 2026 | 2025 | |
| Revenue at constant exchange rates: | £’000 | £’000 |
Statutory revenue as reported | 815,779 | 713,044 |
Adjustment for forward contract (gains)/losses | (11,315) | (19,176) |
Adjustment to restate current year at previous year exchange rates | 9,759 | – |
Revenue at constant exchange rates | 814,223 | 693,868 |
Year-on-year revenue growth at constant exchange rates | 17.3% | n/a |
| 2026 | 2025 | |
| Adjusted profit before tax: | £’000 | £’000 |
Statutory profit before tax | 149,964 | 118,000 |
Cost reduction programme | 14,925 | – |
– reported in production costs | 2,859 | – |
– reported in engineering costs | 6,110 | – |
– reported in distribution costs | 3,350 | – |
– reported in administrative expenses | 2,606 | – |
Loss of office payable to Executive Director | 1,980 | – |
– reported in administrative expenses | 1,980 | – |
Closure of drug delivery business | 666 | 2,059 |
– reported in production costs | (250) | – |
– reported in engineering costs | 916 | 2,059 |
Closure of the Edinburgh research facility | – | 2,320 |
– reported in engineering costs | – | 2,320 |
Other interest payable on historical and non-recurring tax matters | 419 | 4,852 |
– reported in financial income | (2,450) | – |
– reported in financial expenses | 2,869 | 4,852 |
Adjusted profit before tax | 167,954 | 127,231 |
| 2026 | 2025 | |
| Adjusted profit after tax: | £’000 | £’000 |
Statutory profit after tax | 118,9 60 | 83,757 |
Cost reduction programme (net of tax) | 11,301 | – |
Loss of office payable to Executive Director (net of tax) | 1,485 | – |
Closure of drug delivery business (net of tax) | 500 | 1,544 |
Closure of Edinburgh research facility (net of tax) | – | 1,740 |
Other interest payable on historical and non-recurring tax matters (net of tax) | 1,031 | 4,026 |
Prior year adjustment taxation charge on historical and non-recurring tax matters | (2,584) | 9,15 4 |
Adjusted profit after tax | 130,693 | 100,221 |
| 2026 | 2025 | |
| Adjusted earnings per share: | pence | pence |
Statutory earnings per share | 163.5 | 115.2 |
Cost reduction programme (net of tax) | 15.5 | – |
Loss of office payable to Executive Director (net of tax) | 2.0 | – |
Closure of drug delivery business (net of tax) | 0.7 | 2.1 |
Closure of the Edinburgh research facility (net of tax) | – | 2.4 |
Other interest payable on historical and non-recurring tax matters (net of tax) | 1.4 | 5.5 |
Taxation prior year adjustments | (3.6) | 12.6 |
Adjusted earnings per share | 179.5 | 137.8 |
| 2026 | 2025 | |
| Adjusted operating profit: | £’000 | £’000 |
Statutory operating profit | 135,325 | 107,8 8 5 |
Cost reduction programme | 14,925 | – |
Loss of office payable to Executive Director | 1,980 | – |
Closure of drug delivery business | 666 | 2,059 |
Closure of the Edinburgh research facility | – | 2,320 |
Other interest payable on historical and non-recurring tax matters | – | – |
Adjusted operating profit | 152,896 | 112,264 |
| 2026 | 2025 | |
| Industrial Metrology | £’000 | £’000 |
Operating profit | 66,357 | 74,130 |
Cost reduction programme | 9,098 | – |
Loss of office payable to Executive Director | 1,244 | – |
Closure of Edinburgh research facility | – | 1,378 |
Adjusted Industrial Metrology operating profit | 76,699 | 75,508 |
| 2026 | 2025 | |
| Position Measurement | £’000 | £’000 |
Operating profit | 67, 23 0 | 46,010 |
Cost reduction programme | 3,833 | – |
Loss of office payable to Executive Director | 416 | – |
Closure of Edinburgh research facility | – | 618 |
Adjusted Position Measurement operating profit | 71,479 | 46,628 |
| 2026 | 2025 | |
| Specialised Technologies | £’000 | £’000 |
Operating profit | 1,738 | (12,255) |
Cost reduction programme | 1,994 | – |
Loss of office payable to Executive Director | 320 | – |
Closure of drug delivery business | 666 | 2,059 |
Closure of Edinburgh research facility | – | 324 |
Adjusted Specialised Technologies operating profit | 4,718 | (9,872) |
| 2026 | 2025 | |
| Adjusted operating profit at constant exchange rates: | £’000 | £’000 |
Adjusted operating profit | 152,896 | 112,264 |
Adjustment for forward contract (gains)/losses | (11,315) | (19,176) |
Adjustment to restate current year at previous year exchange rates | 9,800 | – |
Adjusted operating profit at constant exchange rates | 151,381 | 93,088 |
Year-on-year adjusted operating profit increase at constant exchange rates | 62.6% | – |
| 2026 | 2025 | |
| Adjusted cash flow conversion from operating activities: | £’000 | £’000 |
Statutory cash flow from operating activities | 110,530 | 147,896 |
Cash effect of adjusting items | 18,207 | – |
Income taxes paid | 36,681 | 6,207 |
Proceeds from sale of property, plant and equipment and intangible assets | 3,885 | 4,887 |
Purchase of property, plant and equipment and intangible assets | (48,288) | (56,558) |
Adjusted cash flow from operating activities | 121,015 | 102,432 |
Adjusted operating profit | 152,896 | 112,264 |
Adjusted cash flow conversion from operating activities | 79.1% | 91.2% |
| Restated | ||
| 2026 | 2025 | |
| £’000 | £’000 | |
Adjusted profit after tax | 130,693 | 100,221 |
Net financial income (net of tax) | (8,574) | (8,845) |
Adjusted profit after tax before net financial income | 122,119 | 91,376 |
| Restated | Restated | ||
| 2026 | 2025 | 2024 | |
| Return on invested capital (ROIC): | £’000 | £’000 | £’000 |
Total equity | 984,132 | 925,864 | 896,265 |
Less cash and cash equivalents | (148,301) | (87,420) | (122,293) |
Less bank deposits | (142,649) | (186,226) | (95,542) |
Add net employee benefits | 8,073 | 9,688 | 10,504 |
Less reimbursement right | (14,566) | (12,909) | (12,116) |
Add/(less) deferred tax on net retirement benefit & reimbursement right asset | 898 | (4) | (232) |
Add borrowings | 1,986 | 2,884 | 3,522 |
Add lease liabilities | 11,518 | 12,761 | 15,022 |
Add amounts owed to joint ventures | 15,948 | 14,530 | 8,475 |
Invested capital | 717,039 | 679,168 | 703,605 |
Average invested capital | 698,104 | 691,387 | 671,844 |
Return on invested capital | 17.5% | 13.2% | 13.6% |
| Fair value | |
| recognised on | |
| acquisition | |
| £’000 | |
Cash | 4,198 |
Property, plant & equipment | 1,358 |
Investment properties | 350 |
Trade receivables | 677 |
Other receivables | 120 |
Inventories | 47 |
Current tax receivable | 121 |
Trade payables | (59) |
Other payables | (271) |
Contract liabilities | (196) |
Deferred tax | (2) |
Net identifiable assets acquired | 6,343 |
Goodwill | 1,095 |
Net assets acquired | 7,438 |